Ben-Gurion University Researchers Identify Cellular Stress Switch Governing Life-or-Death Decision

Researchers at Ben-Gurion University have identified the molecular mechanism by which stressed cells choose between survival and programmed cell death, a discovery that could reshape cancer treatment strategies and cardiac medicine.^[1][2]

The research centers on two proteins, DNAJB12 and DNAJB14, which function as protective guardians within the endoplasmic reticulum network.^[1][2] Under moderate stress conditions, these proteins block self-destruction pathways, allowing cells to persist. Cancer cells exploit this same protective system to resist chemotherapy, maintaining their resilience against treatment.^[1][2]

The critical turning point occurs when stress exceeds a threshold. At that point, the protective proteins break down, triggering apoptosis – the cell’s programmed death sequence.^[1][2] According to Leila Abu Madi, a research partner on the project, this mechanism could become a therapeutic target for cancer treatment by forcing malignant cells to die when conventional approaches fail.^[1][2]

The survival pathway extends beyond cancer biology. The same mechanism also delays heart cell death during oxygen deprivation following a heart attack, suggesting potential applications in cardiac recovery and protection.^[1][2]

The findings were published in the journal Redox Biology.^[1][2] The research builds on earlier work identifying what scientists termed “explosive immune cells” – a separate but related discovery from Ben-Gurion and Stanford researchers examining cellular stress responses in immune function.^[3][4]

The identification of this cellular decision point represents a shift in therapeutic strategy: rather than simply attacking cancer cells from outside, researchers may now target the internal stress-response mechanisms that allow malignant cells to survive conventional treatment. By understanding when and how these protective proteins fail, scientists can potentially design interventions that force cancer cells across the survival threshold into programmed death.